Home > Insider Trading > Filing (0001179110-15-016059)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1578845	Allergan Plc	AGN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1361580	Nesli Basgoz	Clonshaugh Business And Technology Park, Coolock, Co. Dublin D17 E400		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares, Par Value $0.0001	Acquisiton	2015-12-07	2,300	$82.53	6,362	No	4	M	Direct
Ordinary Shares, Par Value $0.0001	Disposition	2015-12-07	2,300	$312.96	4,062	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Employee Stock Option (right to buy)	Disposition	2015-12-07	2,300	$0.00	2,300	$82.53

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
459		2016-05-18	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $312.93 to $312.986, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
This option became vested and exercisable in four equal installments commencing on May 18, 2006.